U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C15H17ClN2O2
Molecular Weight 292.761
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLIMBAZOLE

SMILES

CC(C)(C)C(=O)C(OC1=CC=C(Cl)C=C1)N2C=CN=C2

InChI

InChIKey=OWEGWHBOCFMBLP-UHFFFAOYSA-N
InChI=1S/C15H17ClN2O2/c1-15(2,3)13(19)14(18-9-8-17-10-18)20-12-6-4-11(16)5-7-12/h4-10,14H,1-3H3

HIDE SMILES / InChI

Molecular Formula C15H17ClN2O2
Molecular Weight 292.761
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Climbazole is a topical antifungal agent commonly used in the treatment of human fungal skin infections such as dandruff[2] and eczema. Climbazole is an antimycotic agent with a high in vitro and in vivo efficacy against P. ovale. After a 1-week washout and a 4-week treatment the clinical evaluation showed a successful reduction of dandruff under the climbazole 0.65% shampoo, skin redness and itching in 80% of the volunteers and a mild improvement in 20% of the volunteers. The cosmetic acceptability was very good by the majority. It is concluded that the formulation tested is effective in the treatment of moderate to severe dandruff. It is most commonly found as an active ingredient in OTC anti-dandruff and anti-fungal products, including shampoos, lotions and conditioners. May cause localized irritation of the skin with symptoms including redness, rashes and itching

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
shampoo
Route of Administration: Topical
In Vitro Use Guide
climbazole (CLIM) showed good in vitro activity against M. pachydermatis with the the range of MICs (Minimal Inhibitory Concentration ) was between < 0.06 and 1 ug/ml with an empirical median mean of 0.06 ug/ml;
Substance Class Chemical
Record UNII
9N42CW7I54
Record Status Validated (UNII)
Record Version